Floatz logo

94 assets in Chronic Myelomonocytic Leukemia

Therapeutic assets addressing Chronic Myelomonocytic Leukemia, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Pevonedistat
Chronic Myelomonocytic Leukemia
TakedaP3BB (70)
Venetoclax
Chronic Myelomonocytic Leukemia
Servier Bio-Innovation LLCP2/3BB (68)
Astx727
Chronic Myelomonocytic Leukemia
Taiho Oncology, Inc.P3BB (66)
Azacitidine
Chronic Myelomonocytic Leukemia
The University of Hong KongP3BB (66)
Cyclosporin A
Chronic Myelomonocytic Leukemia
Fred Hutchinson Cancer CenterP2BB (66)
Idarubicin
Chronic Myelomonocytic Leukemia
Fred Hutchinson Cancer CenterP3BB (66)
Melphalan
Chronic Myelomonocytic Leukemia
City of Hope Medical CenterP2BB (66)
Cytarabine
Chronic Myelomonocytic Leukemia
Fred Hutchinson Cancer CenterP3BB (65)
Tacrolimus
Chronic Myelomonocytic Leukemia
City of Hope Medical CenterP2BB (65)
Busulfanum
Chronic Myelomonocytic Leukemia
Center for International Blood and Marrow Transplant ResearchP3BB (64)
Cyclophosphamide
Chronic Myelomonocytic Leukemia
Center for International Blood and Marrow Transplant ResearchP3BB (64)
Decitabine
Chronic Myelomonocytic Leukemia
Fred Hutchinson Cancer CenterP3BB (64)
Dexasone
Chronic Myelomonocytic Leukemia
Indiana UniversityP3BB (64)
Fludarabine
Chronic Myelomonocytic Leukemia
City of Hope Medical CenterP3BB (64)
Nivestim
Chronic Myelomonocytic Leukemia
City of Hope Medical CenterP3BB (64)
Cedazuridine
Chronic Myelomonocytic Leukemia
The University of Hong KongP3B (63)
Cladribine
Chronic Myelomonocytic Leukemia
M.D. Anderson Cancer CenterP2/3B (63)
Mitoxantrone
Chronic Myelomonocytic Leukemia
Fred Hutchinson Cancer CenterP2B (63)
Etoposide
Chronic Myelomonocytic Leukemia
Mayo ClinicP3B (62)
Methotrexate
Chronic Myelomonocytic Leukemia
Fred Hutchinson Cancer CenterP3B (61)
Equine Atg
Chronic Myelomonocytic Leukemia
DKMS gemeinnützige GmbHP3B (60)
Guadecitabine
Chronic Myelomonocytic Leukemia
University of Southern CaliforniaP2B (60)
Rituximab
Chronic Myelomonocytic Leukemia
Prelude TherapeuticsP2B (60)
Sirolimus
Chronic Myelomonocytic Leukemia
City of Hope Medical CenterP2B (59)
Thiotepa
Chronic Myelomonocytic Leukemia
Leland MethenyP2/3B (59)
Carboplatin
Chronic Myelomonocytic Leukemia
OHSU Knight Cancer InstituteP2B (58)
Clofarabine
Chronic Myelomonocytic Leukemia
M.D. Anderson Cancer CenterP2B (58)
Enasidenib
Chronic Myelomonocytic Leukemia
Heinrich-Heine University, DuesseldorfP2B (58)
Anti-Human T-Lymphocyte Immunoglobulin, Rabbit
Chronic Myelomonocytic Leukemia
Fred Hutchinson Cancer CenterP2B (57)
Ipilimumab
Chronic Myelomonocytic Leukemia
OHSU Knight Cancer InstituteP2B (57)
Lenalidomide
Chronic Myelomonocytic Leukemia
Heinrich-Heine University, DuesseldorfP2B (57)
Vorinostat
Chronic Myelomonocytic Leukemia
OHSU Knight Cancer InstituteP2B (57)
Cis-Diamminedichloroplatinum Ii
Chronic Myelomonocytic Leukemia
National Cancer Institute (NCI)P2CCC (55)
Mesna
Chronic Myelomonocytic Leukemia
Center for International Blood and Marrow Transplant ResearchP2CCC (55)
Nogitecan
Chronic Myelomonocytic Leukemia
National Cancer Institute (NCI)P2CCC (55)
Pomalidomide
Chronic Myelomonocytic Leukemia
National Cancer Institute (NCI)P2CCC (55)
Recombinant Human Granulocyte Colony-Stimulating Factor
Chronic Myelomonocytic Leukemia
Fred Hutchinson Cancer CenterP2CCC (55)
Ruxolitinib
Chronic Myelomonocytic Leukemia
Center for International Blood and Marrow Transplant ResearchP2CCC (55)
Veliparib
Chronic Myelomonocytic Leukemia
National Cancer Institute (NCI)P2CCC (55)
Arsenic Trioxide
Chronic Myelomonocytic Leukemia
The University of Hong KongP2CCC (54)
Treosulfan
Chronic Myelomonocytic Leukemia
Fred Hutchinson Cancer CenterP2CCC (54)
Ptcy
Chronic Myelomonocytic Leukemia
Center for International Blood and Marrow Transplant ResearchP2CCC (53)
Oxaliplatin
Chronic Myelomonocytic Leukemia
OHSU Knight Cancer InstituteP2CCC (52)
Abatacept Recombinant
Chronic Myelomonocytic Leukemia
Center for International Blood and Marrow Transplant ResearchP2CCC (51)
Cpx-351
Chronic Myelomonocytic Leukemia
National Cancer Institute (NCI)P2CCC (51)
Ebx-102
Chronic Myelomonocytic Leukemia
Imperial College LondonP2CCC (51)
Gemtuzumab Ozogamicin
Chronic Myelomonocytic Leukemia
M.D. Anderson Cancer CenterP2CCC (51)
Isocyclophosphamide
Chronic Myelomonocytic Leukemia
Mayo ClinicP2CCC (51)
NK-92
Chronic Myelomonocytic Leukemia
M.D. Anderson Cancer CenterP2CCC (51)
Palifermin
Chronic Myelomonocytic Leukemia
City of Hope Medical CenterP2CCC (51)
Showing 1 to 50 of 94 assets
PreviousPage 1 of 2Next